newsfilter
← Latest News
PR Newswire·

INVO Receives 510(k) FDA Clearance for Expanded Use of the INVOcell Device

INVOcell now cleared for 5-day incubation period Supporting data reflects improved patient outcomes, similar to IVF SARASOTA, Fla., June 27, 2023 /PRNewswire/ -- INVO Bioscience, Inc. (NASDAQ:INVO) ("INVO" or the